PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
28-Oct-2025 Domain Therapeutics Doses First Patients in Phase I/II Trial of DT-7012 Targeting CCR8 in Solid Tumors Domain Therapeutics
27-Oct-2025 Quell Therapeutics to Unveil Promising Data for QEL-005, a Novel CAR-Treg Cell Therapy for Complex Autoimmune Diseases, at ACR Convergence 2025 Quell Therapeutics
27-Oct-2025 Lundbeck and OpenAI join forces to unlock innovation and boost productivity Lundbeck
27-Oct-2025 NICE recommends Bayer’s Nubeqa® (darolutamide) plus androgen deprivation therapy as a treatment option for patients with hormone-sensitive metastatic prostate cancer NICE
27-Oct-2025 AMS to participate in upcoming investor conferences in November and December AMS
24-Oct-2025 ONWARD Medical Successfully Raises Over EUR 50 Million in Capital Increase ONWARD Medical
24-Oct-2025 Personalized Medicine Biomarkers Market 2025–2033: Trends, Growth Drivers, and Market Size Forecast to USD 72.06 Billion Acumen Research And Consulting
23-Oct-2025 All-in-One CRO Solution Lindus Health Welcomes Heather Davis as Vice President of US Clinical Operations Lindus Health
23-Oct-2025 Tezspire approved in the EU for chronic rhinosinusitis with nasal polyps AstraZeneca, Amgen
23-Oct-2025 Groundbreaking new projects launched to lower the cost of monoclonal antibody production LifeArc
22-Oct-2025 Sanofi’s efdoralprin alfa met all primary and key secondary endpoints in alpha-1 antitrypsin deficiency emphysema phase 2 study Sanofi
22-Oct-2025 ONWARD Medical Launches Capital Increase for Indicative Amount of EUR 50 Million ONWARD Medical
22-Oct-2025 Curia Sterile Drug Product Facility Named Massachusetts Manufacturer of the Year Curia
22-Oct-2025 Biocomposites launches SYNICEM™ spacers in the U.S. Biocomposites
22-Oct-2025 Indonesia's Legacy in the Global Vaccine Landscape: Bio Farma and DCVMN Strengthen Health Resilience through Global Partnership Bio Farma
21-Oct-2025 Upperton Expands High Precision Filling Capability at Nottingham Facility Upperton Pharma Solutions
21-Oct-2025 Iksuda presents encouraging IKS014 Phase 1 data at ESMO Iksuda
21-Oct-2025 selectION Demonstrates Safety and Disease-Modifying Mechanism of Action of its Investigational Drug, si-544, in Phase 1b Proof-of-Concept Trial in Psoriasis, a T Cell-Mediated Autoimmune Disease selectION, Inc.
20-Oct-2025 Newly Published Paper Describes Discovery that Powers Enzymatic Makeovers for GLP 1 Like Peptides Sethera Therapeutics
20-Oct-2025 ImmunOs Therapeutics Reports Promising Clinical Activity of IOS-1002 in Advanced Solid Tumors ImmunOs Therapeutics